Teva Pharmaceutical Industries Aktie

NeuKaufen Kaufen Verkaufen Verkaufen

Aktien-Sparplan anlegen Aktien-Sparplan anlegen

14,70 EUR -0,20 EUR -1,34 %

21.05.2025

STU

16,58 USD +0,01 USD +0,06 %

nachbörslich21.05.2025

BTT

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Div. Rendite0,00%

WKN883035

ISINUS8816242098

SymbolTEVA

Teva Pharmaceutical Industries Aktien News

Sortieren:Datum Meistgelesen

10.02.25BenzingaAxsome Therapeutics Resolves Generic Patent Litigation With Teva Over Depression Drug, Analyst Maintains Axsome As 'Top Pick For 2025'

09.02.25GlobesTeva files to raise first capital since 2016

02.02.25BenzingaNVIDIA, Teva Pharmaceutical And UPS Are Among Top Large Cap Losers Last Week (Jan 27-Jan 31): Are The Others In Your Portfolio?

02.02.25GlobesAnalysts remain positive on Teva

30.01.25BenzingaTeva Pharmaceutical Indus Options Trading: A Deep Dive into Market Sentiment

30.01.25ZacksTEVA Stock Down 14% Despite Q4 Earnings & Revenues Beat Estimates

30.01.25BenzingaWhat Analysts Are Saying About Teva Pharmaceutical Indus Stock

29.01.25MotleyFoolWhy Teva Pharmaceutical Stock Is Sinking Today

29.01.25MotleyFoolTeva Pharmaceutical Industries (TEVA) Q4 2024 Earnings Call Transcript

29.01.25ZacksTeva Pharmaceutical Industries (TEVA) Reports Q4 Earnings: What Key Metrics Have to Say

29.01.25BenzingaTeva Pharmaceutical Stock Falls On Q4 Earnings: What's Going On?

29.01.25GlobesTeva falls sharply on disappointing 2025 guidance

27.01.25BenzingaPeering Into Teva Pharmaceutical Indus's Recent Short Interest

27.01.25GlobeNewswireAlvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab)

17.01.25BenzingaTeva Challenges Drug Price Law's Impact On Innovation, Generics

13.01.25GlobeNewswireTeva Announces Collaboration to Commercialize Formycon’s Biosimilar Candidate to Eylea® (aflibercept) in major parts of Europe and in Israel

10.01.25GlobeNewswireSamsung Bioepis and Teva Enter into a Strategic Partnership for Commercialization of EPYSQLI® (eculizumab-aagh) in the United States

09.01.25BenzingaCatalyst Pharmaceuticals Settles Patent Litigation Case With Teva Pharmaceutical

09.01.25ZacksCPRX Stock Rises 17% on Settling Firdapse Patent Litigation With Teva

08.01.25GlobesUS analysts list Teva, Wix in 2025 top picks

25.12.24BenzingaTesla, Avinger, Jet.Ai, Teva, And Netflix: Why These 5 Stocks Are On Investors' Radars Ahead Of Christmas

23.12.24GlobeNewswireTeva to Present at the 43rd Annual J.P. Morgan Healthcare Conference

22.12.24BenzingaTeva Pharmaceutical, Li Auto, And Darden Restaurants Are Among Top Large Cap Gainers Last Week (December 16-20): Are The Others In Your Portfolio?

20.12.24GlobeNewswireTeva to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance at 8 a.m. ET on January 29, 2025

18.12.24BenzingaTeva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases

18.12.24GlobesTeva share price at 6-year high after trial results

18.12.24ZacksSNY, TEVA Stocks Jump on Encouraging Data From IBD Drug Study

18.12.24ZacksStrength Seen in Teva Pharmaceutical Industries (TEVA): Can Its 26.5% Jump Turn into More Strength?

18.12.24BenzingaNukkleus, Micron, Teva Pharmaceutical, Quantum Computing, Tesla: Why These 5 Stocks Are On Investors' Radars Today

17.12.24GlobesTeva jumps sharply on bowel disease drug results

17.12.24BenzingaRCI Hospitality, Quantum Computing, Teva Pharmaceutical, Tesla And Other Big Stocks Moving Higher On Monday

17.12.24BenzingaWhy Are Teva And Sanofi Stocks Trading Higher On Tuesday?

17.12.24GlobeNewswireTeva and Sanofi Announce Duvakitug (Anti-TL1A) Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn’s Disease

11.12.24GlobeNewswireTeva Announces New Patient Access Program with Direct Relief to Provide Access to Inhalers for Uninsured Patients

09.12.24GlobesTeva divests from Japanese JV with Takeda

06.12.24GlobeNewswireTeva Announces Agreement to Divest Teva-Takeda, its Business Venture in Japan

04.12.24GlobeNewswireTeva Presents Positive Efficacy and Safety Data of AJOVY® (fremanezumab) for the Prevention of Episodic Migraine in Children and Adolescents from Phase 3 SPACE Trial

28.11.24ZacksTEVA Stock Down 10% in a Month: Should You Buy the Dip?

26.11.24GlobeNewswireTeva to Present at the 7th Annual Evercore ISI HealthCONx Conference

19.11.24GlobesDespite price cuts, Tesla loses its shine in Israel

Teva Pharmaceutical Industries News

Teva Pharmaceutical Industries News: auf dieser Seite finden Sie alle Teva Pharmaceutical Industries News und Nachrichten zur Teva Pharmaceutical Industries Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Teva Pharmaceutical Industries News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Teva Pharmaceutical Industries News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.